 |
인쇄하기
취소
|
Samyang Genex to gear up export for European market
Samyang Genex said it has recently signed an agreement with an European multinational firm to supply its anticancer drug “Genexol“ (paclitaxel), paving a way to make inroad into an European market.
This agreement will provide Samyang with an annual revenue of around $10 million, according to a company official.
Samyang utilizes advanced plant cell culture-derived paclitaxel. Advance plant...
This agreement will provide Samyang with an annual revenue of around $10 million, according to a company official.
Samyang utilizes advanced plant cell culture-derived paclitaxel. Advance plant...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.